Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of mRNA export from nucleus	TPR IWS1 SUPT6H	1.67e-05	11	98	3	GO:0010793
GeneOntologyBiologicalProcess	regulation of ribonucleoprotein complex localization	TPR IWS1 SUPT6H	2.87e-05	13	98	3	GO:2000197
GeneOntologyBiologicalProcess	ribonucleoprotein complex localization	TPR IWS1 SUPT6H	3.64e-05	14	98	3	GO:0071166
GeneOntologyBiologicalProcess	regulation of RNA export from nucleus	TPR IWS1 SUPT6H	6.74e-05	17	98	3	GO:0046831
GeneOntologyBiologicalProcess	protein-DNA complex organization	TPR KMT2B KDM4C CHAF1A EZH1 IWS1 CDC45 RIF1 UBR5 SUPT6H BANP SENP6 PHF14 TP53BP1 HDAC2	7.18e-05	999	98	15	GO:0071824
GeneOntologyBiologicalProcess	regulation of nucleobase-containing compound transport	TPR IWS1 SUPT6H	1.12e-04	20	98	3	GO:0032239
GeneOntologyBiologicalProcess	B cell activation involved in immune response	NKX2-3 RIF1 SUPT6H PHF14 TP53BP1	1.21e-04	101	98	5	GO:0002312
GeneOntologyBiologicalProcess	heterochromatin formation	TPR KMT2B EZH1 RIF1 UBR5 HDAC2	1.28e-04	163	98	6	GO:0031507
GeneOntologyBiologicalProcess	response to caffeine	RYR1 RYR3 HDAC2	1.30e-04	21	98	3	GO:0031000
GeneOntologyCellularComponent	chromosome, telomeric region	SSB XRCC1 EZH1 RIF1 TP53BP1 HDAC2	1.72e-04	176	97	6	GO:0000781
Domain	ZF_CCHC_HIVEP	HIVEP1 HIVEP3	2.67e-05	2	97	2	PS51811
Domain	Ryanrecept_TM4-6	RYR1 RYR3	7.98e-05	3	97	2	IPR009460
Domain	SV2	SV2A SV2C	7.98e-05	3	97	2	IPR022308
Domain	RyR	RYR1 RYR3	7.98e-05	3	97	2	PF02026
Domain	Ryanodine_rcpt	RYR1 RYR3	7.98e-05	3	97	2	IPR003032
Domain	Pentapeptide_4	SV2A SV2C	7.98e-05	3	97	2	PF13599
Domain	RR_TM4-6	RYR1 RYR3	7.98e-05	3	97	2	PF06459
Domain	Ryan_recept	RYR1 RYR3	7.98e-05	3	97	2	IPR013333
Domain	5peptide_repeat	SV2A SV2C	1.59e-04	4	97	2	IPR001646
Domain	EPHD	KMT2B KDM4C PHF14	1.95e-04	22	97	3	PS51805
Domain	RIH_assoc	RYR1 RYR3	3.95e-04	6	97	2	PF08454
Domain	RIH_assoc-dom	RYR1 RYR3	3.95e-04	6	97	2	IPR013662
Domain	RIH_dom	RYR1 RYR3	3.95e-04	6	97	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR3	3.95e-04	6	97	2	IPR014821
Domain	Tesmin/TSO1-like_CXC	EZH1 KIF4B	3.95e-04	6	97	2	IPR033467
Domain	Ryanodine_recept-rel	RYR1 RYR3	3.95e-04	6	97	2	IPR015925
Domain	-	RYR1 RYR3	3.95e-04	6	97	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR3	3.95e-04	6	97	2	PF01365
Domain	CXC	EZH1 KIF4B	3.95e-04	6	97	2	SM01114
Domain	Ins145_P3_rec	RYR1 RYR3	3.95e-04	6	97	2	PF08709
Domain	Prefoldin	TPR URI1 KIF4A TLE5	5.37e-04	72	97	4	IPR009053
Domain	BEN	NACC1 BANP	9.39e-04	9	97	2	PF10523
Domain	BEN_domain	NACC1 BANP	9.39e-04	9	97	2	IPR018379
Domain	BEN	NACC1 BANP	9.39e-04	9	97	2	PS51457
Domain	BEN	NACC1 BANP	9.39e-04	9	97	2	SM01025
Domain	Znf_FYVE_PHD	KMT2B KDM4C PHRF1 PHF14 WDFY3	1.02e-03	147	97	5	IPR011011
Domain	MIR	RYR1 RYR3	1.17e-03	10	97	2	PS50919
Domain	MIR	RYR1 RYR3	1.17e-03	10	97	2	PF02815
Domain	MIR	RYR1 RYR3	1.17e-03	10	97	2	SM00472
Domain	MIR_motif	RYR1 RYR3	1.17e-03	10	97	2	IPR016093
Domain	PHD	KMT2B KDM4C PHRF1 PHF14	1.19e-03	89	97	4	SM00249
Domain	Kinesin_motor_CS	KIF1B KIF4A KIF4B	1.25e-03	41	97	3	IPR019821
Domain	Znf_PHD	KMT2B KDM4C PHRF1 PHF14	1.29e-03	91	97	4	IPR001965
Domain	Kinesin-like_fam	KIF1B KIF4A KIF4B	1.44e-03	43	97	3	IPR027640
Domain	ZF_PHD_2	KMT2B KDM4C PHRF1 PHF14	1.52e-03	95	97	4	PS50016
Domain	KINESIN_MOTOR_1	KIF1B KIF4A KIF4B	1.54e-03	44	97	3	PS00411
Domain	-	KIF1B KIF4A KIF4B	1.54e-03	44	97	3	3.40.850.10
Domain	Kinesin_motor_dom	KIF1B KIF4A KIF4B	1.54e-03	44	97	3	IPR001752
Domain	Kinesin	KIF1B KIF4A KIF4B	1.54e-03	44	97	3	PF00225
Domain	KINESIN_MOTOR_2	KIF1B KIF4A KIF4B	1.54e-03	44	97	3	PS50067
Domain	KISc	KIF1B KIF4A KIF4B	1.54e-03	44	97	3	SM00129
Domain	ZF_PHD_1	KMT2B KDM4C PHRF1 PHF14	1.58e-03	96	97	4	PS01359
Domain	BRCT	XRCC1 TP53BP1	4.31e-03	19	97	2	PF00533
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	SP1 LEO1 KDM4C NACC1 EZH1 RCOR2 RIF1 TLE5 HDAC2	2.14e-05	301	72	9	MM15983
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR SP1 HIVEP1 KMT2B LEO1 WEE1 NACC1 EML4 CHAF1A KIF1B MINK1 PHRF1 RREB1 IWS1 RIF1 SENP6 GIGYF2 PHF14 PRRC2A TP53BP1 LRRFIP1	5.93e-15	774	100	21	15302935
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR WBP11 HIVEP1 MAP1B EML4 CHAF1A GPATCH1 KIF4A XRCC1 RREB1 RIF1 FANCI WBP4 SENP6 GIGYF2 PHF14 PRRC2A TP53BP1 HDAC2	2.90e-11	954	100	19	36373674
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR POLR1A MAP1B PHRF1 KIF4A SSB EDC4 RIF1 UBE2O UBR5 SUPT6H FANCI GIGYF2 PRRC2A TP53BP1 HDAC2	6.22e-11	653	100	16	22586326
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR WBP11 NACC1 MINK1 KIF4A PPP6R1 EDC4 RCOR2 UBE2O UBR5 GIGYF2 KIF4B WDFY3 NEURL4 PRRC2A TP53BP1 LRRFIP1 HDAC2	2.84e-10	963	100	18	28671696
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	POLR1A MAP1B KIF4A SSB XRCC1 EDC4 AP3B1 RIF1 PHF14 PRRC2A TP53BP1 HDAC2	1.62e-09	394	100	12	27248496
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	HIVEP1 KMT2B NACC1 CHAF1A KIF4A XRCC1 RREB1 IWS1 RIF1 UBE2O FANCI SENP6 PHF14 HDAC2	2.39e-09	608	100	14	36089195
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR KMT2B MAP1B KIF4A EDC4 AP3B1 UBE2O GIGYF2 NAA30 PRRC2A TP53BP1 LRRFIP1 HDAC2	6.67e-09	549	100	13	38280479
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	TPR LEO1 NACC1 KIF4A RCOR2 RIF1 GIGYF2 KIF4B TP53BP1	7.92e-09	203	100	9	22083510
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	TPR WBP11 URI1 LEO1 EML4 KIF4A SSB PPP6R1 AP3B1 IWS1 RIF1 UBE2O UBR5 SUPT6H GIGYF2 PRRC2A LRRFIP1 HDAC2 AHNAK2	1.93e-08	1415	100	19	28515276
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TPR SP1 LEO1 CHAF1A KIF4A IWS1 RIF1 FANCI EEF2K PRRC2A TP53BP1 LRRFIP1	2.44e-08	503	100	12	16964243
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TPR WBP11 POLR1A LEO1 NACC1 CHAF1A KIF4A XRCC1 IWS1 CDC45 RIF1 UBR5 SUPT6H FANCI PHF14 HDAC2	3.30e-08	1014	100	16	32416067
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	SP1 URI1 MAP1B RYR3 SENP6 PRRC2A TP53BP1 HDAC2	8.63e-08	191	100	8	20195357
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PRKD2 WEE1 NACC1 CHAF1A RALYL PHRF1 CLSTN2 PPP6R1 RREB1 EZH1 RCOR2 UBR5 SV2A PIP4K2A WDFY3 HDAC2	1.22e-07	1116	100	16	31753913
Pubmed	Human transcription factor protein interaction networks.	SP1 WBP11 HIVEP1 KMT2B NACC1 SSB PPP6R1 XRCC1 EDC4 RREB1 RIF1 UBE2O TLE5 BANP GIGYF2 PRRC2A TP53BP1 HDAC2	1.25e-07	1429	100	18	35140242
Pubmed	Systematic identification of factors for provirus silencing in embryonic stem cells.	EML4 CHAF1A RCOR2 RIF1 UBR5 TP53BP1 HDAC2	3.16e-07	153	100	7	26365490
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR HIVEP1 KMT2B NACC1 PPP6R1 RREB1 RCOR2 UBR5 GIGYF2 HDAC2	3.74e-07	418	100	10	34709266
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR MAP1B NACC1 GPATCH1 KIF4A PPP6R1 EDC4 RIF1 UBE2O SENP6 GIGYF2 PRRC2A TP53BP1 AHNAK2	4.79e-07	934	100	14	33916271
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	TPR SP1 CHAF1A KIF4A EDC4 RREB1 RIF1 TP53BP1 AHNAK2	5.24e-07	332	100	9	32786267
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	WBP11 NACC1 CHAF1A EZH1 IWS1 SUPT6H FANCI WBP4 PHF14 TP53BP1	1.06e-06	469	100	10	27634302
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	HIVEP1 LEO1 WEE1 KIF1B PPP6R1 UBR5 SUPT6H PIP4K2A BANP SENP6 TP53BP1	1.07e-06	588	100	11	38580884
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	PRKD2 HIVEP1 POLR1A MAP1B PPP6R1 IWS1 UBE2O UBR5 SUPT6H FANCI GIGYF2 NEURL4 PRRC2A TP53BP1	1.14e-06	1005	100	14	19615732
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	WBP11 URI1 AHI1 LEO1 WEE1 EML4 KIF1B SSB RREB1 AP3B1 RIF1 GIGYF2 RPGR NEURL4 TP53BP1 HDAC2	1.14e-06	1321	100	16	27173435
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	WBP11 URI1 LEO1 MINK1 PPP6R1 VPS25 XRCC1 AP3B1 IWS1 RIF1 FANCI SLC12A7 NEURL4 PRRC2A	1.88e-06	1049	100	14	27880917
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	TPR POLR1A GPATCH1 EDC4 GIGYF2 PRRC2A LRRFIP1	2.04e-06	202	100	7	24639526
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	TPR WBP11 KMT2B LEO1 KIF4A SSB RIF1 UBE2O TP53BP1 LRRFIP1	2.09e-06	506	100	10	30890647
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	WBP11 URI1 POLR1A MAP1B GPATCH1 IWS1 CDC45 NAA30	2.61e-06	300	100	8	28561026
Pubmed	A novel pro-Arg motif recognized by WW domains.	WBP11 KMT2B PRRC2A	2.73e-06	10	100	3	10744724
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	WBP11 HIVEP1 KMT2B NACC1 KIF4A SSB XRCC1 EDC4 RREB1 UBR5 FANCI PRRC2A TP53BP1 HDAC2	3.35e-06	1103	100	14	34189442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PRKD2 KMT2B PIEZO1 PPP6R1 EDC4 RYR1 HIVEP3 EHBP1L1 FANCI CCDC34 BANP WDFY3 HAS3 AHNAK2	3.43e-06	1105	100	14	35748872
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SP1 KMT2B LEO1 CHAF1A GPATCH1 PHRF1 KIF4A XRCC1 RREB1 IWS1 RIF1 SUPT6H BANP PHF14 HDAC2	4.37e-06	1294	100	15	30804502
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	CHAF1A RCOR2 SUPT6H PHF14 TP53BP1 HDAC2	4.97e-06	150	100	6	28242625
Pubmed	De novo genic mutations among a Chinese autism spectrum disorder cohort.	HIVEP3 GIGYF2 WDFY3	4.98e-06	12	100	3	27824329
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	POLR1A MAP1B WEE1 EML4 UBR5 EEF2K PRRC2A	5.08e-06	232	100	7	25515538
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	SP1 KMT2B CHAF1A PCDHA10 XRCC1 RYR1 SLC24A1 HDAC2	5.15e-06	329	100	8	17474147
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	KMT2B POLR1A PIEZO1 CHAF1A MINK1 PHRF1 KIF4A XRCC1 EDC4 AP3B1 IWS1 RIF1 SUPT6H PHF14 UNC93B1 PRRC2A	5.67e-06	1497	100	16	31527615
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	TPR SP1 DIS3L2 WEE1 NACC1 CHAF1A GJC2 EDC4 IWS1 CDC45 UBR5 MTF1 GIGYF2 RASEF PHF14	5.91e-06	1327	100	15	32694731
Pubmed	A protein interaction network for pluripotency of embryonic stem cells.	SP1 NACC1 RIF1 HDAC2	6.00e-06	41	100	4	17093407
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TPR MAP1B NACC1 CHAF1A KIF4A PPP6R1 XRCC1 RIF1 UBR5 BANP TP53BP1 HDAC2	6.70e-06	857	100	12	25609649
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	POLR1A MAP1B EML4 MINK1 AP3B1 PIP4K2A GIGYF2 NAA30 PRRC2A LRRFIP1 AHNAK2	7.79e-06	724	100	11	36232890
Pubmed	KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway.	KIF4A KIF4B	8.18e-06	2	100	2	36482480
Pubmed	The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential.	KIF4A KIF4B	8.18e-06	2	100	2	30081192
Pubmed	53BP1-RIF1: sculpting the DNA repair focus in 3D.	RIF1 TP53BP1	8.18e-06	2	100	2	31792447
Pubmed	Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis.	KIF4A KIF4B	8.18e-06	2	100	2	31067151
Pubmed	Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors.	RYR1 RYR3	8.18e-06	2	100	2	9489997
Pubmed	The block of ryanodine receptors selectively inhibits fetal myoblast differentiation.	RYR1 RYR3	8.18e-06	2	100	2	12640042
Pubmed	Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of corticotropin-releasing factor on adrenocorticotropin secretion.	RYR1 RYR3	8.18e-06	2	100	2	14592949
Pubmed	Cellular motor protein KIF-4 associates with retroviral Gag.	KIF4A KIF4B	8.18e-06	2	100	2	10559369
Pubmed	Delay in synthesis of the 3' splice site promotes trans-splicing of the preceding 5' splice site.	SP1 WBP4	8.18e-06	2	100	2	15837427
Pubmed	DSB repair pathway choice is regulated by recruitment of 53BP1 through cell cycle-dependent regulation of Sp1.	SP1 TP53BP1	8.18e-06	2	100	2	33730584
Pubmed	KIF4 regulates midzone length during cytokinesis.	KIF4A KIF4B	8.18e-06	2	100	2	21565503
Pubmed	Genetic ablation of interacting with Spt6 (Iws1) causes early embryonic lethality.	IWS1 SUPT6H	8.18e-06	2	100	2	30208029
Pubmed	A novel microtubule-based motor protein (KIF4) for organelle transports, whose expression is regulated developmentally.	KIF4A KIF4B	8.18e-06	2	100	2	7929562
Pubmed	Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors.	RYR1 RYR3	8.18e-06	2	100	2	9799464
Pubmed	Sp1-independent downregulation of NHEJ in response to BER deficiency.	SP1 XRCC1	8.18e-06	2	100	2	31812125
Pubmed	Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development.	RYR1 RYR3	8.18e-06	2	100	2	17118445
Pubmed	RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle.	RYR1 RYR3	8.18e-06	2	100	2	11500519
Pubmed	Structure and function of the two tandem WW domains of the pre-mRNA splicing factor FBP21 (formin-binding protein 21).	WBP11 WBP4	8.18e-06	2	100	2	19592703
Pubmed	53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy.	RIF1 TP53BP1	8.18e-06	2	100	2	31822909
Pubmed	Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells.	KIF4A KIF4B	8.18e-06	2	100	2	31486502
Pubmed	The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress.	RIF1 TP53BP1	8.18e-06	2	100	2	33141022
Pubmed	Assignment of the kinesin family member 4 genes (KIF4A and KIF4B) to human chromosome bands Xq13.1 and 5q33.1 by in situ hybridization.	KIF4A KIF4B	8.18e-06	2	100	2	10773663
Pubmed	Missense Pathogenic variants in KIF4A Affect Dental Morphogenesis Resulting in X-linked Taurodontism, Microdontia and Dens-Invaginatus.	KIF4A KIF4B	8.18e-06	2	100	2	31616463
Pubmed	Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.	RYR1 RYR3	8.18e-06	2	100	2	12565913
Pubmed	Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors.	RYR1 RYR3	8.18e-06	2	100	2	9192302
Pubmed	Kif4 regulates the expression of VEGFR1 through the PI3K/Akt signaling pathway in RAW264.7 monocytes/macrophages.	KIF4A KIF4B	8.18e-06	2	100	2	28350061
Pubmed	A novel PHD-finger protein 14/KIF4A complex overexpressed in lung cancer is involved in cell mitosis regulation and tumorigenesis.	KIF4A PHF14	8.18e-06	2	100	2	28160558
Pubmed	Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle.	RYR1 RYR3	8.18e-06	2	100	2	7556644
Pubmed	Kif4 interacts with EB1 and stabilizes microtubules downstream of Rho-mDia in migrating fibroblasts.	KIF4A KIF4B	8.18e-06	2	100	2	24658398
Pubmed	RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection.	RIF1 TP53BP1	8.18e-06	2	100	2	23333305
Pubmed	Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction.	RYR1 RYR3	8.18e-06	2	100	2	15894801
Pubmed	Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3.	RYR1 RYR3	8.18e-06	2	100	2	9817784
Pubmed	Structural basis for the ATP-induced isomerization of kinesin.	KIF4A KIF4B	8.18e-06	2	100	2	23500491
Pubmed	53BP1 regulates DSB repair using Rif1 to control 5' end resection.	RIF1 TP53BP1	8.18e-06	2	100	2	23306437
Pubmed	Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein.	KIF4A KIF4B	8.18e-06	2	100	2	9658142
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	PRKD2 URI1 LEO1 WEE1 NACC1 PPP6R1 EDC4 AP3B1 IWS1 UBR5 GIGYF2 EEF2K PJA1	8.93e-06	1038	100	13	26673895
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR KIF1B XRCC1 EHBP1L1 PRRC2A TP53BP1 LRRFIP1 AHNAK2	9.92e-06	360	100	8	33111431
Pubmed	Transcription-coupled nucleotide excision repair is coordinated by ubiquitin and SUMO in response to ultraviolet irradiation.	TPR LEO1 IWS1 SUPT6H HDAC2	1.19e-05	102	100	5	31722399
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	HIVEP1 KMT2B EML4 CHAF1A RREB1 EZH1 UBE2O FANCI HDAC2	1.35e-05	495	100	9	27705803
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GPATCH1 KIF1B MINK1 KIF4A AP3B1 RIF1 UBR5 EEF2K RPGR PJA1 PCDH10	1.50e-05	777	100	11	35844135
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SP1 HIVEP1 WEE1 NACC1 AP3B1 RYR1 EHBP1L1 WBP4 WDFY3 AHNAK2	1.58e-05	638	100	10	31182584
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	WBP11 LEO1 MAP1B EML4 MINK1 PPP6R1 AP3B1 CDC45 GIGYF2 SLC12A7	1.86e-05	650	100	10	38777146
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	PEG3 KIF4A RREB1 RYR3 PHF14 KIF4B HDAC2	1.88e-05	284	100	7	29459677
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	TPR MINK1 KIF4A SSB PPP6R1 UBR5 LRRFIP1 HDAC2	2.08e-05	399	100	8	37536630
Pubmed	The functional interactome landscape of the human histone deacetylase family.	TPR PPP6R1 RREB1 RCOR2 RIF1 UBR5 HDAC2	2.11e-05	289	100	7	23752268
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SP1 URI1 HIVEP1 KDM4C PEG3 RCOR2 HIVEP3 RIF1 MTF1 WBP4 PHF14	2.15e-05	808	100	11	20412781
Pubmed	Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.	PRKD2 MAP1B UBR5 TLE5 GIGYF2	2.21e-05	116	100	5	30652415
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR3	2.45e-05	3	100	2	18403125
Pubmed	Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor.	RYR1 RYR3	2.45e-05	3	100	2	11171121
Pubmed	Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis.	SV2A SV2C	2.45e-05	3	100	2	23617838
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR3	2.45e-05	3	100	2	7876312
Pubmed	Tumor formation via loss of a molecular motor protein.	KIF4A KIF4B	2.45e-05	3	100	2	16890532
Pubmed	KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons.	KIF4A KIF4B	2.45e-05	3	100	2	19158085
Pubmed	Identification of the human homologue of mouse KIF4, a kinesin superfamily motor protein.	KIF4A KIF4B	2.45e-05	3	100	2	10978527
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR3	2.45e-05	3	100	2	22948152
Pubmed	Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.	SP1 HDAC2	2.45e-05	3	100	2	20697349
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR3	2.45e-05	3	100	2	10788707
Pubmed	Expression of SV2 isoforms during rodent brain development.	SV2A SV2C	2.45e-05	3	100	2	23937191
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR3	2.45e-05	3	100	2	7621815
Pubmed	Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns.	SV2A SV2C	2.45e-05	3	100	2	33588752
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR3	2.45e-05	3	100	2	10473538
Interaction	ZNF330 interactions	WBP11 KMT2B LEO1 CHAF1A KIF4A SSB XRCC1 RREB1 IWS1 UBE2O TLE5 SUPT6H FANCI SENP6 PHF14	4.04e-09	446	98	15	int:ZNF330
Interaction	SMC5 interactions	TPR WBP11 HIVEP1 MAP1B EML4 CHAF1A GPATCH1 KIF4A XRCC1 RREB1 RIF1 FANCI WBP4 SENP6 GIGYF2 PHF14 PJA1 PRRC2A TP53BP1 HDAC2	5.83e-08	1000	98	20	int:SMC5
Interaction	TERF2IP interactions	WBP11 HIVEP1 KMT2B LEO1 NACC1 CHAF1A KIF4A XRCC1 RREB1 RIF1 SUPT6H BANP SENP6 WDFY3	4.48e-07	552	98	14	int:TERF2IP
Interaction	SIRT7 interactions	TPR POLR1A MAP1B PHRF1 KIF4A SSB EDC4 RIF1 UBE2O UBR5 SUPT6H FANCI GIGYF2 PRRC2A TP53BP1 HDAC2	5.70e-07	744	98	16	int:SIRT7
Interaction	H3-3A interactions	HIVEP1 KMT2B KDM4C NACC1 EML4 CHAF1A KIF4A XRCC1 RREB1 IWS1 RIF1 FANCI SENP6 PHF14 LRRFIP1 HDAC2	6.23e-07	749	98	16	int:H3-3A
Interaction	RUVBL2 interactions	URI1 AHI1 POLR1A LEO1 MAP1B EML4 CHAF1A IWS1 UBE2O UBR5 SUPT6H SENP6 LRRFIP1 HDAC2	1.64e-06	616	98	14	int:RUVBL2
Interaction	NUP43 interactions	HIVEP1 KMT2B LEO1 GPATCH1 PHRF1 CLSTN2 IWS1 RIF1 UBR5 SUPT6H FANCI SENP6 HDAC2 AHNAK2	1.95e-06	625	98	14	int:NUP43
Interaction	CSNK2A1 interactions	SP1 KMT2B POLR1A WAS LEO1 WEE1 KIF1B MINK1 PHRF1 SSB XRCC1 IWS1 UBE2O TLE5 SUPT6H PIP4K2A HDAC2	3.30e-06	956	98	17	int:CSNK2A1
Interaction	RCOR1 interactions	TPR SP1 HIVEP1 KMT2B EML4 PPP6R1 RREB1 UBR5 GIGYF2 TP53BP1 LRRFIP1 HDAC2	4.95e-06	494	98	12	int:RCOR1
Interaction	POU5F1 interactions	TPR SP1 LEO1 NACC1 KIF4A XRCC1 RCOR2 RIF1 UBR5 FANCI GIGYF2 TP53BP1 HDAC2	5.01e-06	584	98	13	int:POU5F1
Interaction	H3C3 interactions	HIVEP1 KMT2B CHAF1A KIF4A RREB1 IWS1 RIF1 UBE2O SUPT6H FANCI PHF14 HDAC2	5.05e-06	495	98	12	int:H3C3
Interaction	EFTUD2 interactions	TPR WBP11 LEO1 EML4 CHAF1A GPATCH1 KIF4A SSB PPP6R1 AP3B1 IWS1 RIF1 UBE2O UBR5 MTF1 WBP4 GIGYF2 PRRC2A LRRFIP1 HDAC2 AHNAK2	5.06e-06	1449	98	21	int:EFTUD2
Interaction	PHF21A interactions	TPR HIVEP1 KMT2B PPP6R1 RREB1 RCOR2 UBR5 BANP GIGYF2 HDAC2	6.65e-06	343	98	10	int:PHF21A
Interaction	H2BC21 interactions	KMT2B LEO1 MAP1B CHAF1A KIF4A SSB XRCC1 RREB1 IWS1 RIF1 SUPT6H PHF14 PRRC2A HDAC2	6.73e-06	696	98	14	int:H2BC21
Interaction	CSNK2A2 interactions	DIS3L2 POLR1A WAS WEE1 KIF1B MINK1 PHRF1 XRCC1 UBE2O PIP4K2A PHF14 TP53BP1 HDAC2 AHNAK2	9.58e-06	718	98	14	int:CSNK2A2
Interaction	KDM1A interactions	TPR HIVEP1 KMT2B LEO1 KDM4C NACC1 EML4 CHAF1A PPP6R1 RREB1 RCOR2 UBR5 TLE5 GIGYF2 TP53BP1 HDAC2	1.17e-05	941	98	16	int:KDM1A
Interaction	DDX20 interactions	CHAF1A AP3B1 UBE2O GIGYF2 UNC93B1 PRRC2A TP53BP1 HDAC2	1.37e-05	224	98	8	int:DDX20
Interaction	CBX3 interactions	KMT2B NACC1 CHAF1A KIF4A SSB XRCC1 RREB1 EZH1 RIF1 UBE2O SENP6 TP53BP1 HDAC2	1.47e-05	646	98	13	int:CBX3
Interaction	HDAC1 interactions	TPR SP1 HIVEP1 KMT2B KDM4C EML4 CHAF1A KIF4A PPP6R1 RREB1 RCOR2 UBR5 BANP GIGYF2 PHF14 LRRFIP1 HDAC2	2.27e-05	1108	98	17	int:HDAC1
Interaction	ELOA interactions	HIVEP1 LEO1 NACC1 CHAF1A EZH1 SUPT6H PIP4K2A HDAC2	2.39e-05	242	98	8	int:ELOA
Interaction	POLR1G interactions	WBP11 URI1 KMT2B POLR1A LEO1 CHAF1A XRCC1 RREB1 IWS1 SUPT6H PHF14	2.57e-05	489	98	11	int:POLR1G
Interaction	SMC2 interactions	EML4 KIF4A XRCC1 GIGYF2 KIF4B FGFR3 UNC93B1 LRRFIP1 HDAC2	2.81e-05	323	98	9	int:SMC2
Interaction	BRCA1 interactions	TPR SP1 HIVEP1 POLR1A WEE1 CHAF1A KIF1B PEG3 SSB PPP6R1 XRCC1 RIF1 UBR5 SUPT6H FANCI TP53BP1 LRRFIP1 HDAC2	2.91e-05	1249	98	18	int:BRCA1
Interaction	SUMO2 interactions	TPR SP1 CHAF1A KIF4A EDC4 RREB1 RCOR2 RIF1 SENP6 TP53BP1 HDAC2 AHNAK2	2.96e-05	591	98	12	int:SUMO2
Interaction	PRKDC interactions	TPR SP1 MAP1B CHAF1A PPP6R1 XRCC1 UBE2O UBR5 MTF1 FGFR3 UNC93B1 LRRFIP1 HDAC2	3.16e-05	695	98	13	int:PRKDC
Interaction	KIF4B interactions	KIF4A KIF4B HDAC2	3.90e-05	14	98	3	int:KIF4B
Interaction	LGR4 interactions	TPR POLR1A GPATCH1 EDC4 GIGYF2 TYW1 PRRC2A LRRFIP1	4.21e-05	262	98	8	int:LGR4
Interaction	EML4 interactions	MAP1B EML4 CHAF1A GIGYF2 LRRFIP1 HDAC2	5.57e-05	137	98	6	int:EML4
Interaction	SUPT16H interactions	POLR1A LEO1 CHAF1A SSB IWS1 UBE2O UBR5 MTF1 SUPT6H PHF14	5.83e-05	442	98	10	int:SUPT16H
Interaction	SNRNP40 interactions	WBP11 HIVEP1 KMT2B GPATCH1 PHRF1 XRCC1 UBR5 SUPT6H FANCI WBP4 SENP6 HDAC2	6.10e-05	637	98	12	int:SNRNP40
Interaction	TNRC6A interactions	KMT2B EDC4 UBE2O UBR5 GIGYF2 PRRC2A TP53BP1 AHNAK2	6.71e-05	280	98	8	int:TNRC6A
Interaction	TEC interactions	POLR1A WAS MAP1B PIP4K2A TP53BP1	7.78e-05	90	98	5	int:TEC
Interaction	RPRD2 interactions	URI1 POLR1A LEO1 PHRF1 SUPT6H HDAC2	7.94e-05	146	98	6	int:RPRD2
Interaction	TXNIP interactions	TPR MAP1B UBE2O UBR5 PJA1 NEURL4 HDAC2	7.95e-05	212	98	7	int:TXNIP
Interaction	CDKN1A interactions	SP1 KMT2B CDC45 IGFBP2 UBR5 SUPT6H GIGYF2 TP53BP1 HDAC2	8.90e-05	375	98	9	int:CDKN1A
Interaction	PIP4K2A interactions	EDC4 AP3B1 IWS1 EHBP1L1 UBE2O PIP4K2A TP53BP1	8.93e-05	216	98	7	int:PIP4K2A
Interaction	TMA16 interactions	UBE2O SUPT6H PIP4K2A PRRC2A TP53BP1	1.01e-04	95	98	5	int:TMA16
Interaction	BRCA2 interactions	SP1 WEE1 KIF4A XRCC1 CDC45 FANCI PHF14 TP53BP1 HDAC2	1.07e-04	384	98	9	int:BRCA2
Interaction	RUVBL1 interactions	URI1 POLR1A MAP1B EML4 CHAF1A UBE2O UBR5 SUPT6H TP53BP1 LRRFIP1 HDAC2	1.10e-04	575	98	11	int:RUVBL1
Interaction	H2BC8 interactions	KMT2B CHAF1A KIF4A XRCC1 RREB1 IWS1 RIF1 UBE2O FANCI SENP6 PHF14	1.12e-04	576	98	11	int:H2BC8
Interaction	ERCC6 interactions	TPR POLR1A LEO1 IWS1 RIF1 SUPT6H HDAC2	1.12e-04	224	98	7	int:ERCC6
Interaction	H3C1 interactions	TPR WBP11 KMT2B LEO1 KDM4C CHAF1A KIF4A SSB XRCC1 CDC45 RIF1 SENP6 TP53BP1 HDAC2	1.14e-04	901	98	14	int:H3C1
Interaction	SSRP1 interactions	POLR1A LEO1 CHAF1A SSB XRCC1 IWS1 RIF1 UBE2O UBR5 SUPT6H PHF14 PRRC2A	1.21e-04	685	98	12	int:SSRP1
Interaction	BCL6 interactions	SP1 KMT2B NACC1 SSB TLE5 TP53BP1 HDAC2	1.28e-04	229	98	7	int:BCL6
Interaction	ACTC1 interactions	TPR SP1 WBP11 KMT2B WAS LEO1 KIF4A SSB RIF1 UBE2O TP53BP1 LRRFIP1	1.37e-04	694	98	12	int:ACTC1
Interaction	BUB3 interactions	KMT2B MAP1B UBE2O UBR5 WBP4 TP53BP1 HDAC2	1.39e-04	232	98	7	int:BUB3
Interaction	DCTN1 interactions	TPR AHI1 EML4 GPATCH1 KIF1B PPP6R1 UBE2O RPGR LRRFIP1 HDAC2	1.53e-04	497	98	10	int:DCTN1
Interaction	H2BC3 interactions	POLR1A MAP1B KIF4A SSB EDC4 RIF1 PHF14 TP53BP1 HDAC2	1.62e-04	406	98	9	int:H2BC3
Interaction	GPN3 interactions	URI1 POLR1A LEO1 EHBP1L1 SUPT6H	1.76e-04	107	98	5	int:GPN3
Interaction	PHF21B interactions	RREB1 BANP HDAC2	1.84e-04	23	98	3	int:PHF21B
Interaction	SMARCA5 interactions	TPR POLR1A EML4 CHAF1A KIF4A MTF1 FGFR3 LRRFIP1 HDAC2	1.91e-04	415	98	9	int:SMARCA5
Interaction	POLR2L interactions	URI1 POLR1A NACC1 PHRF1 SUPT6H BANP	1.95e-04	172	98	6	int:POLR2L
Interaction	SUB1 interactions	PRKD2 SP1 MINK1 SSB UBE2O UBR5 TP53BP1	2.05e-04	247	98	7	int:SUB1
Interaction	ZNF207 interactions	TPR UBE2O UBR5 WBP4 TP53BP1	2.09e-04	111	98	5	int:ZNF207
Interaction	CHEK2 interactions	TPR WEE1 XRCC1 UBE2O UBR5 SV2A TP53BP1	2.20e-04	250	98	7	int:CHEK2
Interaction	H2BC1 interactions	XRCC1 IWS1 UBE2O PHF14 PRRC2A HDAC2	2.35e-04	178	98	6	int:H2BC1
Interaction	NUDC interactions	SP1 POLR1A LEO1 MAP1B EML4 MINK1 RPGR TP53BP1	2.40e-04	337	98	8	int:NUDC
Interaction	RBPJ interactions	SP1 KMT2B NACC1 CHAF1A XRCC1 RCOR2 HDAC2	2.43e-04	254	98	7	int:RBPJ
Interaction	NXF1 interactions	TPR SP1 WBP11 POLR1A MAP1B KDM4C RALYL KIF4A EDC4 IWS1 UBE2O SUPT6H FANCI UNC93B1 WDFY3 TP53BP1 HDAC2	2.45e-04	1345	98	17	int:NXF1
Interaction	NAA40 interactions	TPR MAP1B NACC1 GPATCH1 KIF4A PPP6R1 EDC4 RIF1 UBE2O SENP6 GIGYF2 PRRC2A TP53BP1 AHNAK2	2.66e-04	978	98	14	int:NAA40
Interaction	PPP6R3 interactions	SP1 MAP1B EML4 CHAF1A PPP6R1 LRRFIP1 HDAC2	2.67e-04	258	98	7	int:PPP6R3
Interaction	CDK2AP1 interactions	LEO1 CHAF1A XRCC1 PHF14 HDAC2	2.78e-04	118	98	5	int:CDK2AP1
Interaction	IGF1 interactions	IGFBP2 BANP IGSF1	3.00e-04	27	98	3	int:IGF1
Interaction	MED4 interactions	AHI1 MAP1B EDC4 UBE2O UBR5 TLE5 PIP4K2A TP53BP1 LRRFIP1	3.46e-04	450	98	9	int:MED4
Interaction	ERICH2 interactions	IWS1 ERICH2	3.47e-04	6	98	2	int:ERICH2
Interaction	PYHIN1 interactions	WBP11 MAP1B RREB1 UBR5 SUPT6H GIGYF2 PHF14 HDAC2	3.60e-04	358	98	8	int:PYHIN1
Interaction	ACTR1A interactions	EML4 IWS1 CDC45 UBR5 LRRFIP1 HDAC2 AHNAK2	3.84e-04	274	98	7	int:ACTR1A
Interaction	APEX1 interactions	AHI1 HIVEP1 KMT2B KDM4C CHAF1A XRCC1 RREB1 IWS1 RIF1 FANCI GIGYF2 RPGR NEURL4 PRRC2A TP53BP1 HDAC2	4.00e-04	1271	98	16	int:APEX1
Interaction	MOB3C interactions	TPR MINK1 KIF4A SSB PPP6R1 UBR5 LRRFIP1 HDAC2	4.02e-04	364	98	8	int:MOB3C
Interaction	CCDC71 interactions	SSB IWS1 SUPT6H HDAC2	4.20e-04	72	98	4	int:CCDC71
Interaction	UHRF2 interactions	TPR PEG3 KIF4A XRCC1 RIF1 FANCI	4.37e-04	200	98	6	int:UHRF2
Interaction	SMC4 interactions	MAP1B EML4 KIF4A XRCC1 UNC93B1 LRRFIP1 HDAC2	4.46e-04	281	98	7	int:SMC4
Interaction	TCEA1 interactions	LEO1 IWS1 UBE2O UBR5 SUPT6H	4.50e-04	131	98	5	int:TCEA1
Interaction	FXR1 interactions	PRKD2 HIVEP1 NACC1 RALYL EDC4 RCOR2 TLE5 GIGYF2 PRRC2A TP53BP1 HDAC2	4.59e-04	679	98	11	int:FXR1
Interaction	DNAAF10 interactions	URI1 POLR1A CHAF1A VPS25 FGFR3	4.82e-04	133	98	5	int:DNAAF10
Interaction	DPY30 interactions	KMT2B UBR5 FANCI TP53BP1 LRRFIP1 HDAC2	4.86e-04	204	98	6	int:DPY30
Interaction	FBXW11 interactions	HIVEP1 POLR1A MAP1B WEE1 EML4 UBR5 EEF2K PCDH10 PRRC2A	4.97e-04	473	98	9	int:FBXW11
Interaction	SLFN11 interactions	TPR POLR1A MAP1B AP3B1 RIF1 EEF2K TP53BP1 HDAC2	4.98e-04	376	98	8	int:SLFN11
Interaction	MOV10 interactions	WBP11 POLR1A MAP1B KDM4C KIF1B KIF4A EDC4 IWS1 UBE2O TLE5 FANCI PHF14 WDFY3 PRRC2A TP53BP1 HDAC2	4.99e-04	1297	98	16	int:MOV10
Interaction	MRE11 interactions	TPR CHAF1A XRCC1 CDC45 TP53BP1 LRRFIP1 HDAC2	5.06e-04	287	98	7	int:MRE11
Interaction	CENPA interactions	HIVEP1 KMT2B LEO1 CHAF1A KIF4A RREB1 SENP6 PHF14	5.07e-04	377	98	8	int:CENPA
Interaction	GFI1B interactions	LEO1 RCOR2 UBR5 TLE5 HDAC2	5.34e-04	136	98	5	int:GFI1B
Interaction	CAPZB interactions	TPR SP1 POLR1A LEO1 MINK1 SSB EDC4 AP3B1 UBE2O UBR5 PIP4K2A PRRC2A TP53BP1 LRRFIP1	5.39e-04	1049	98	14	int:CAPZB
Interaction	RPL13AP3 interactions	PRKD2 MAP1B MINK1	5.47e-04	33	98	3	int:RPL13AP3
Interaction	XRCC6 interactions	TPR MAP1B CHAF1A GPATCH1 PHRF1 KIF4A SSB XRCC1 RIF1 UBE2O WBP4 BANP TP53BP1	5.50e-04	928	98	13	int:XRCC6
Interaction	TIMELESS interactions	SP1 CHAF1A SSB XRCC1 CDC45	5.52e-04	137	98	5	int:TIMELESS
Interaction	DDX23 interactions	WBP11 LEO1 MAP1B PHRF1 IWS1 UBR5 SUPT6H WBP4 PIP4K2A	5.52e-04	480	98	9	int:DDX23
Interaction	CT45A5 interactions	EDC4 AP3B1 UBE2O PHF14	5.69e-04	78	98	4	int:CT45A5
Interaction	PARP1 interactions	SP1 HIVEP1 POLR1A LEO1 KIF4A XRCC1 RREB1 UBE2O MTF1 SUPT6H FANCI BANP SENP6 PHF14 TP53BP1 HDAC2	5.85e-04	1316	98	16	int:PARP1
Interaction	RELA interactions	SP1 DIS3L2 POLR1A WAS PPP6R1 TLE5 BANP TP53BP1 HDAC2	5.95e-04	485	98	9	int:RELA
Interaction	SKP2 interactions	PRKD2 SP1 POLR1A WEE1 XRCC1 TLE5 PJA1	6.08e-04	296	98	7	int:SKP2
Interaction	CHD4 interactions	TPR WBP11 LEO1 EML4 CHAF1A IWS1 UBE2O MTF1 SUPT6H GIGYF2 PHF14 LRRFIP1 HDAC2	6.09e-04	938	98	13	int:CHD4
Interaction	MIER1 interactions	SP1 MAP1B PHF14 HDAC2	6.27e-04	80	98	4	int:MIER1
Interaction	ZNF66 interactions	SP1 RREB1	6.43e-04	8	98	2	int:ZNF66
Interaction	TOP3B interactions	PRKD2 KMT2B PIEZO1 KIF1B PPP6R1 EDC4 RYR1 HIVEP3 EHBP1L1 FANCI CCDC34 BANP WDFY3 HAS3 PRRC2A TP53BP1 AHNAK2	6.82e-04	1470	98	17	int:TOP3B
Interaction	CHP1 interactions	KIF1B SLC9A4 UNC93B1 TP53BP1	7.20e-04	83	98	4	int:CHP1
Interaction	MGARP interactions	PRKD2 PPP6R1 CDC45 RIF1 FANCI WDFY3	7.57e-04	222	98	6	int:MGARP
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	PRKD2 KMT2B GPATCH1 PEG3 RSPH6A PPP6R1 XRCC1 RYR1 KCNJ14 HRC	2.81e-04	1192	100	10	chr19q13
Cytoband	4q21.23	CDS1 WDFY3	3.61e-04	13	100	2	4q21.23
Cytoband	Ensembl 112 genes in cytogenetic band chr6p24	SMIM13 HIVEP1 RREB1	4.94e-04	70	100	3	chr6p24
Cytoband	19q13.3	PRKD2 RSPH6A HRC	7.84e-04	82	100	3	19q13.3
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR3	3.58e-05	3	63	2	287
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	WBP11 URI1 MAP1B PHRF1 RYR1	4.18e-04	181	63	5	694
GeneFamily	BEN domain containing	NACC1 BANP	4.23e-04	9	63	2	422
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF1B KIF4A KIF4B	5.50e-04	46	63	3	622
GeneFamily	PHD finger proteins	KMT2B PHRF1 PHF14	3.82e-03	90	63	3	88
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	URI1 HIVEP1 MAP1B KDM4C AP3B1 RIF1 UBR5 WBP4 PIP4K2A GIGYF2 PHF14 RPGR WDFY3 TP53BP1 LRRFIP1	8.68e-07	856	100	15	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM	DIS3L2 WEE1 CHAF1A KIF4A RCOR2 FNDC1 IGFBP2 FANCI CCDC34	8.73e-06	354	100	9	M39061
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGBP	DIS3L2 WEE1 KIF4A RCOR2 IGFBP2 FANCI CCDC34 FGFR3	2.01e-05	300	100	8	M39059
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	TPR URI1 HIVEP1 WEE1 GPATCH1 KIF4A AP3B1 UBE2O SUPT6H BANP NAA30 RPGR WDFY3	2.19e-06	564	99	13	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_500	SP1 PEG3 SSB PPP6R1 RIF1 TLE5 PRRC2A	1.33e-05	167	99	7	gudmap_developingGonad_e16.5_testes_500_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	URI1 AHI1 MAP1B WEE1 AP3B1 UBE2O SUPT6H CCDC34 SENP6 NAA30 RPGR WDFY3	2.11e-05	595	99	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	SP1 MAP1B KIF1B PEG3 CLSTN2 RIF1 GIGYF2 RPGR WDFY3 HDAC2	2.52e-05	417	99	10	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000	SP1 WBP11 PEG3 SSB PPP6R1 RIF1 TLE5 PIP4K2A PJA1 PRRC2A	3.20e-05	429	99	10	gudmap_developingGonad_e14.5_ testes_1000_k5
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500	CDS1 WEE1 CDC45 RIF1 FANCI	1.33e-04	105	99	5	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000	CDS1 MAP1B RYR3 CREBRF HIVEP3 FNDC1 EHBP1L1 PLCH2 RASEF FAM110C LRRFIP1 AHNAK2	1.57e-04	734	99	12	gudmap_developingLowerUrinaryTract_adult_bladder_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	URI1 WEE1 AP3B1 IWS1 RIF1 UBE2O SUPT6H CCDC34 PLCH2 NAA30 WDFY3	1.68e-04	629	99	11	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	AHI1 MAP1B SSB AP3B1 IWS1 RIF1 UBR5 CCDC34 PLCH2 PIP4K2A PHF14 NAA30 FGFR3 RPGR	1.95e-04	989	99	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000	SP1 PEG3 SSB PPP6R1 RIF1 TLE5 PJA1 PRRC2A	2.30e-04	349	99	8	gudmap_developingGonad_P2_testes_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	TPR AHI1 SSB AP3B1 BANP PHF14	2.38e-04	186	99	6	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHAF1A KIF4A CDC45 RIF1 FANCI CCDC34 FGFR3	1.25e-07	172	100	7	2b6cd84c946b1e800caba452ae70145ea285fec1
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative\|Int-URO / Disease, condition lineage and cell class	WEE1 CHAF1A KIF4A CDC45 FANCI CCDC34 FAM110C	3.48e-07	200	100	7	99acc1ea01288efdd5b166aa20d66735f2bbe543
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAF1A KIF4A CDC45 SLC9A4 CCDC34 FAM110C	3.62e-06	183	100	6	e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative\|Multiple_Sclerosis / Disease, Lineage and Cell Type	CHAF1A KIF4A CDC45 FANCI CCDC34 KIF4B	4.23e-06	188	100	6	6c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MAP1B PEG3 RALYL CLSTN2 SV2A SV2C	4.23e-06	188	100	6	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	(3)_Macrophage_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	KIF4A CDC45 IGFBP2 FANCI CCDC34 KIF4B	4.63e-06	191	100	6	b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd
ToppCell	mild-Lymphocytic-Prol._cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	WEE1 CHAF1A KIF4A CDC45 FANCI CCDC34	5.22e-06	195	100	6	9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	WEE1 KIF4A CDC45 FANCI CCDC34 KIF4B	5.37e-06	196	100	6	9591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	WEE1 KIF4A PPP6R1 IGFBP2 FANCI CCDC34	5.37e-06	196	100	6	36ed1918f70b6f5760bb088b15ce422998055cc7
ToppCell	(3)_MNP-(3)_Macrophage_Dividing\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	KIF4A CDC45 IGFBP2 FANCI CCDC34 KIF4B	5.53e-06	197	100	6	048bc4f8fd5d4f394e2384700640f72042336597
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF4A CDC45 FANCI FGFR3 HAS3 AHNAK2	5.53e-06	197	100	6	2430f31d9312338e0ca23bfc6bdb0365340860fd
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	CHAF1A KIF4A CDC45 IGFBP2 FANCI CCDC34	5.69e-06	198	100	6	b2868a897dd96494cf1829c30e0ce508f52efdf3
ToppCell	cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGFBP2 PLCH2 FGFR3 HAS3 FAM110C AHNAK2	5.69e-06	198	100	6	7063d74d79f53d5c59c853a2575f9d3ef12f19ea
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	WEE1 CHAF1A KIF4A CDC45 FANCI CCDC34	5.86e-06	199	100	6	a99516a5760f49a69b0fe45a9b2316e393252966
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	WEE1 CHAF1A KIF4A CDC45 FANCI CCDC34	6.03e-06	200	100	6	8f8b8c225cdc79baf16fe04be89bdb65e404a055
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells\|10w / Sample Type, Dataset, Time_group, and Cell type.	WEE1 CHAF1A KIF4A CDC45 FANCI CCDC34	6.03e-06	200	100	6	a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed
ToppCell	healthy_donor-Lymphocytic-Proliferative_Lymphocyte\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CHAF1A KIF4A CDC45 FANCI CCDC34 KIF4B	6.03e-06	200	100	6	e4eb915c29909cf8535a3603c68976545c05e54b
ToppCell	mild-T/NK_proliferative\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	WEE1 CHAF1A KIF4A CDC45 FANCI CCDC34	6.03e-06	200	100	6	25b4a1a33348e274bd4457efc0d6faa5421c3d31
ToppCell	healthy_donor-Lymphocytic-Proliferative_Lymphocyte-\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CHAF1A KIF4A CDC45 FANCI CCDC34 KIF4B	6.03e-06	200	100	6	415e7556b5ac45688e2c6c30a52bd40e0eb27c7d
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHAF1A KIF4A CDC45 FNDC1 FANCI CCDC34	6.03e-06	200	100	6	1fbed5967fc1922efe4a98f5760ad74fce210c52
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	WAS PIEZO1 RREB1 RYR1 IGSF10 UNC93B1	6.03e-06	200	100	6	26251ed8c7fa7e87973d6f59bd398c88ad025395
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative\|Leuk-UTI / Disease, condition lineage and cell class	WEE1 CHAF1A KIF4A CDC45 FANCI CCDC34	6.03e-06	200	100	6	093e97395be23092229521cc55aaaee8befbc149
ToppCell	mild-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	WEE1 CHAF1A KIF4A CDC45 FANCI CCDC34	6.03e-06	200	100	6	63cc57b9331459efbb73051d174d198a3568b938
ToppCell	3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Lung / Manually curated celltypes from each tissue	CHAF1A KIF4A IGSF10 FANCI CCDC34	3.35e-05	163	100	5	47300dec94dc66e965bf71fafff0a9fd24fae968
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHAF1A KIF4A CDC45 FANCI KIF4B	3.35e-05	163	100	5	3f434015c0cbefb31eeda133c34f75384c5f7e22
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HIVEP1 KMT2B CHAF1A TYW1 SLC24A1	3.65e-05	166	100	5	c8a7d94ed762e5e045ab5f74eef691ddc5f74993
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KIF4A CDC45 FNDC1 FANCI	4.21e-05	171	100	5	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KIF4A CDC45 FNDC1 FANCI	4.21e-05	171	100	5	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHAF1A KIF4A CDC45 FANCI SLC24A1	4.82e-05	176	100	5	581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T\|Lung / Manually curated celltypes from each tissue	CHAF1A KIF4A CDC45 FANCI CCDC34	4.82e-05	176	100	5	a40dfd8c4ba16757ff929b2f03a0628acf334de4
ToppCell	Healthy_Control-Lymphoid-T-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	WEE1 CHAF1A KIF4A FANCI CCDC34	5.51e-05	181	100	5	ac1ee313910c05b1b3cb497bae14565464919c21
ToppCell	mild_COVID-19_(asymptomatic)-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	CHAF1A KIF4A CDC45 FANCI CCDC34	5.66e-05	182	100	5	9adf90bb2808f234d53b89ca0ae07380478204ad
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T\|Liver / Manually curated celltypes from each tissue	KIF4A CDC45 FANCI CCDC34 KIF4B	5.66e-05	182	100	5	81557cdc88777f3bd4e1dd18a760b08fc29122ef
ToppCell	Control-T/NK-proliferating_T/NK\|Control / Disease group,lineage and cell class （2021.01.30）	WEE1 KIF4A CDC45 FANCI CCDC34	5.80e-05	183	100	5	e740f05536d1e4b2512811771928eb65f6696409
ToppCell	URO-Lymphocyte-T_NK-T_NK_proliferative\|URO / Disease, Lineage and Cell Type	KIF4A CDC45 FANCI CCDC34 KIF4B	6.11e-05	185	100	5	0ae9c646679c69a553eda670aef0e0495feb0286
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NACC1 TLE5 PLCH2 FGFR3 PRRC2A	6.27e-05	186	100	5	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MAP1B PEG3 RALYL CLSTN2 SV2A	6.27e-05	186	100	5	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TPR SP1 EML4 IWS1 GIGYF2	6.27e-05	186	100	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NACC1 TLE5 PLCH2 FGFR3 PRRC2A	6.76e-05	189	100	5	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	Int-URO-Lymphocyte-T_NK-T_NK_proliferative\|Int-URO / Disease, Lineage and Cell Type	WEE1 KIF4A CDC45 FANCI KIF4B	6.93e-05	190	100	5	005967c540418b85311308072a07c684f4296aef
ToppCell	normal_Pleural_Fluid-T/NK_cells-Undetermined\|normal_Pleural_Fluid / Location, Cell class and cell subclass	KIF4A CDC45 FANCI CCDC34 KIF4B	6.93e-05	190	100	5	165c61443ff0c8efbdad3b052bb00f46d81c5203
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WEE1 CHAF1A KIF4A CDC45 CCDC34	7.28e-05	192	100	5	e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	WEE1 KIF4A CDC45 FANCI CCDC34	7.46e-05	193	100	5	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CHAF1A CDC45 FANCI IGSF1 DMP1	7.46e-05	193	100	5	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHAF1A KIF4A CDC45 FANCI CCDC34	7.46e-05	193	100	5	cf680afddc08b6481f1b3eee9c57acfaebeac6f0
ToppCell	control-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	7.46e-05	193	100	5	ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHAF1A KIF4A CDC45 FANCI CCDC34	7.65e-05	194	100	5	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	(1)_T_cells_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CHAF1A KIF4A CDC45 FANCI CCDC34	7.65e-05	194	100	5	8f313071933451780309d2174ed27d8cdc734343
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	7.65e-05	194	100	5	9bbb124001fba7450f4639f47f9b720a483e7242
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CHAF1A KIF4A CDC45 FANCI IGSF1	7.65e-05	194	100	5	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CHAF1A KIF4A CDC45 FANCI CCDC34	7.65e-05	194	100	5	a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHAF1A KIF4A CDC45 FANCI CCDC34	7.65e-05	194	100	5	17744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|367C / Donor, Lineage, Cell class and subclass (all cells)	KIF4A CDC45 FANCI CCDC34 KIF4B	7.65e-05	194	100	5	a12b64945e10f00aa983678a02586c59badc1570
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SMIM13 AHI1 CHAF1A FANCI CCDC34	7.65e-05	194	100	5	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CHAF1A KIF4A CDC45 FANCI CCDC34	7.65e-05	194	100	5	e14f66f7584909621b776292fbd52808273fd2ee
ToppCell	Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CHAF1A KIF4A CDC45 FANCI CCDC34	7.83e-05	195	100	5	79ee423df85aa1631b7bdea74eacaf826dfc4a2c
ToppCell	Dividing_cells-Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CHAF1A KIF4A CDC45 FANCI CCDC34	7.83e-05	195	100	5	19829760dfcc0edafd2a2bd80f424a45d039af1f
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CDS1 IGFBP2 RASEF ERICH2 HAS3	7.83e-05	195	100	5	ce1ba5911e8a6ddb07434acc37147c38e94245ff
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CHAF1A KIF4A CDC45 FANCI CCDC34	7.83e-05	195	100	5	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	(1)_T_cells-(1)_T_cells_Dividing\|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	CHAF1A KIF4A CDC45 FANCI CCDC34	7.83e-05	195	100	5	cf00a0b4f341f0487d5b37810abe2952fdd3f6f2
ToppCell	BLOOD--(1)_Activated_T_cells\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	EML4 KIF4A CDC45 TLE5 FANCI	7.83e-05	195	100	5	45515d5da8a8c8242eb70a1bea24fe44eca5407b
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	WEE1 KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	6d80e23f6a1725a3f5ea7263233c55c2ea56f977
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WEE1 KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	bf1d3fae8c01bb3d17c2dafad92b94937c663acd
ToppCell	severe-T/NK_proliferative\|severe / disease stage, cell group and cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	89f005216770dbb84378f5d1f20ca11b0ce40faa
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	WEE1 KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496
ToppCell	mild-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CHAF1A KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	b1d9866d5dfaefdb8bedaf01a750d97987acb3d1
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CHAF1A KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	73f951f7712e0aa3323676b9a4b7944d21d347c4
ToppCell	control-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CHAF1A KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	886f7c865b086d6ebb4a1746865c30af6bbed345
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WEE1 RALYL IGFBP2 TLE5 AHNAK2	8.03e-05	196	100	5	d688350aadc622984d612ae6b2fd7c0113a4ec0f
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WEE1 KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	4f649e3bfd21f21682678828673843a7d51c4ff2
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B WEE1 RYR3 IGSF10 IGFBP2	8.03e-05	196	100	5	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	WEE1 KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	799c290fb3dfacb666dd0dc3c43ec8a86b697ec7
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	KIF4A CDC45 IGFBP2 FANCI CCDC34	8.03e-05	196	100	5	34bd155e6d848eb53d613997c0e244535de30ba3
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WEE1 KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	0c003a767c3b58605099dab64b9df0d8e5d8bc4b
ToppCell	Healthy-T/NK_proliferative\|Healthy / disease group, cell group and cell class	WEE1 KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	91e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCell	Control-T/NK_proliferative\|Control / Disease condition and Cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	8.03e-05	196	100	5	7b7bc25aef49bfd64f79303a92d527bf8188f7a6
ToppCell	severe_COVID-19-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	CHAF1A KIF4A CDC45 FANCI CCDC34	8.22e-05	197	100	5	189d97a6c2ff8803db8cc05e205c9d88dac3911f
ToppCell	ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative\|ICU-SEP / Disease, Lineage and Cell Type	CHAF1A KIF4A CDC45 FANCI CCDC34	8.22e-05	197	100	5	908e91fa16134b61943aea5e8fc0d6fbac8a8c6e
ToppCell	Healthy-T/NK_proliferative\|World / disease group, cell group and cell class	WEE1 KIF4A CDC45 FANCI CCDC34	8.22e-05	197	100	5	e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCell	Control-Myeloid-proliferating_Myeloid_cells\|Control / Disease group,lineage and cell class （2021.01.30）	WEE1 KIF4A CDC45 FANCI CCDC34	8.22e-05	197	100	5	ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e
ToppCell	Healthy/Control-T/NK_proliferative\|World / Disease group and Cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	8.22e-05	197	100	5	4a4d3083938783d6f5b87da02f10e501917da0b4
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / Disease condition and Cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	8.22e-05	197	100	5	718a84e9a8248080f2d964e7c6a3ba183ece9592
ToppCell	severe-T/NK_proliferative\|World / disease stage, cell group and cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	8.22e-05	197	100	5	6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CDS1 CDC45 FANCI KCNJ14 HAS3	8.22e-05	197	100	5	49689a03ab31e53386dbe15c77c09ca3a14ebf4e
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	AHI1 MAP1B CCDC34 PHF14 PRRC2A	8.22e-05	197	100	5	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHAF1A KIF4A CDC45 FANCI CCDC34	8.22e-05	197	100	5	17bd2aef8d8792703973643ec9743efd546b7b69
ToppCell	COVID-19_Moderate-T/NK_proliferative\|COVID-19_Moderate / disease group, cell group and cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCell	severe_COVID-19-T/NK_proliferative\|severe_COVID-19 / disease group, cell group and cell class (v2)	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	ed86b0247006befe55400c287d334d2202b470bd
ToppCell	severe-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	4d8591eabb543ed789f963b507a07c560c76a7c9
ToppCell	(0)_NK_cells-(0)_NK_Dividing\|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb
ToppCell	COVID-19_Moderate-T/NK_proliferative\|World / disease group, cell group and cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CDC45 IGFBP2 FANCI CCDC34 HDAC2	8.42e-05	198	100	5	06888fe2d42ac66ac12157608becd42764e0d034
ToppCell	MS-cycling-\|MS / Condition, Cell_class and T cell subcluster	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	19c5d6b65de490118574b1f86b45c58b3a51df7f
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb
ToppCell	normal_Lung-T/NK_cells-Undetermined\|normal_Lung / Location, Cell class and cell subclass	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	c65cdb54409087014125a76627e5efb5fe8dabc9
ToppCell	distal-1-Hematologic-Proliferating_Macrophage\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KIF4A CDC45 FANCI CCDC34 KIF4B	8.42e-05	198	100	5	df3f5559ecd1f3cd1fd60e39dbad8741309e83a3
ToppCell	normal_Lymph_Node-T/NK_cells-Undetermined\|T/NK_cells / Location, Cell class and cell subclass	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	47d572b9db2843aeb2079f33a852babf67270be4
ToppCell	Caecum-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	d2def132f3efe9305a5501a96ec82efb1f02c3f7
ToppCell	COVID-19_Severe-T/NK_proliferative\|World / disease group, cell group and cell class	CHAF1A KIF4A CDC45 FANCI CCDC34	8.42e-05	198	100	5	48045689d0969ff0a14eee7086b8e19b0d6b6065
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WEE1 CHAF1A KIF4A CDC45 FANCI	8.42e-05	198	100	5	f088badb90c6c2d916195f5649eda102119c9ac6
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	1.87e-05	2	99	2	ctd:C005147
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A	KMT2B WAS KDM4C HIVEP3 SUPT6H PLCH2 LRRFIP1	2.10e-05	192	99	7	1792_UP
Drug	Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	TPR MAP1B KDM4C EDC4 IGFBP2 SUPT6H RPGR	2.40e-05	196	99	7	7124_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	AHI1 KMT2B MAP1B KDM4C MINK1 EHBP1L1 SENP6	2.48e-05	197	99	7	3343_DN
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A	PRKD2 KMT2B WAS SUPT6H SENP6 FGFR3 IGSF1	2.48e-05	197	99	7	1697_DN
Drug	Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A	PRKD2 SP1 MAP1B EDC4 AP3B1 SUPT6H WDFY3	2.56e-05	198	99	7	5346_UP
Drug	Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A	AHI1 MAP1B MINK1 EZH1 SENP6 WDFY3 SLC24A1	2.56e-05	198	99	7	5445_DN
Drug	cis-diammineplatinum(II	RYR1 RYR3	5.60e-05	3	99	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR3	5.60e-05	3	99	2	CID002750949
Drug	8N3-cADPR	RYR1 RYR3	5.60e-05	3	99	2	CID000127713
Drug	aminodantrolene	RYR1 RYR3	5.60e-05	3	99	2	CID009570289
Drug	2-hydroxycarbazole	RYR1 RYR3	5.60e-05	3	99	2	CID000093551
Drug	1,1'-diheptyl-4,4'-bipyridinium	RYR1 RYR3	5.60e-05	3	99	2	CID000080262
Drug	flubendiamide	RYR1 RYR3	5.60e-05	3	99	2	CID011193251
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR3	5.60e-05	3	99	2	CID005748312
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR3	3.27e-05	3	98	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR3	3.27e-05	3	98	2	DOID:8545 (implicated_via_orthology)
Disease	mean corpuscular hemoglobin concentration	SP1 POLR1A PIEZO1 NKX2-3 PPP6R1 RREB1 EZH1 RIF1 SLC9A4 EHBP1L1 UBR5 KIF4B SLC12A7	7.47e-05	1105	98	13	EFO_0004528
Disease	epilepsy (implicated_via_orthology)	MINK1 KIF4A SV2A KIF4B SLC12A7	2.17e-04	163	98	5	DOID:1826 (implicated_via_orthology)
Disease	neuroblastoma (is_implicated_in)	CHAF1A KIF1B	4.83e-04	10	98	2	DOID:769 (is_implicated_in)
Disease	alopecia areata (is_marker_for)	KDM4C HDAC2	4.83e-04	10	98	2	DOID:986 (is_marker_for)
Disease	invasive ductal carcinoma (is_implicated_in)	XRCC1 UBR5	5.89e-04	11	98	2	DOID:3008 (is_implicated_in)
Disease	monocyte percentage of leukocytes	AHI1 POLR1A PIEZO1 KIF1B NKX2-3 TLE5 WDFY3 NEURL4 PGBD2	7.40e-04	731	98	9	EFO_0007989
Disease	left ventricular diastolic function measurement	SP1 RSPH6A PHF14	7.79e-04	54	98	3	EFO_0008204
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP1 HIVEP3	8.32e-04	13	98	2	DOID:0050787 (implicated_via_orthology)
Disease	Alzheimer's disease (implicated_via_orthology)	HIVEP1 RCOR2 HIVEP3	9.13e-04	57	98	3	DOID:10652 (implicated_via_orthology)
Disease	neutrophil count, basophil count	SP1 AHI1 PCDHA10 RREB1 SLC12A7	9.23e-04	224	98	5	EFO_0004833, EFO_0005090
Disease	migraine disorder, type 2 diabetes mellitus	WEE1 RREB1 SENP6	1.06e-03	60	98	3	MONDO_0005148, MONDO_0005277
Disease	platelet-to-lymphocyte ratio	AHI1 KIF1B MINK1 RSPH6A RREB1 SV2C	1.35e-03	363	98	6	EFO_0008446
Disease	obsolete_red blood cell distribution width	SP1 AHI1 KMT2B POLR1A PIEZO1 CHAF1A AP3B1 EHBP1L1 FANCI BANP SV2C SLC12A7	1.69e-03	1347	98	12	EFO_0005192
Disease	ovulation	FANCI PRRC2A	1.80e-03	19	98	2	GO_0030728
Disease	Retinal Degeneration	AHI1 RPGR	2.20e-03	21	98	2	C0035304
Disease	transitional cell carcinoma (is_implicated_in)	XRCC1 FGFR3	2.42e-03	22	98	2	DOID:2671 (is_implicated_in)
Disease	pulmonary hypertension (biomarker_via_orthology)	RYR1 RYR3 HAS3	2.43e-03	80	98	3	DOID:6432 (biomarker_via_orthology)
Disease	red blood cell density measurement	SP1 HIVEP1 POLR1A PIEZO1 NKX2-3 RREB1 UBR5 KIF4B PGBD2	2.65e-03	880	98	9	EFO_0007978
Disease	attempted suicide	IWS1 CCDC34 GIGYF2 FAM110C	2.98e-03	178	98	4	EFO_0004321
Disease	visceral adipose tissue measurement, body mass index	PCDHA10 CLSTN2 RREB1	3.08e-03	87	98	3	EFO_0004340, EFO_0004765
Disease	hepatocellular carcinoma (is_implicated_in)	KMT2B KIF1B XRCC1 RYR3	3.16e-03	181	98	4	DOID:684 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
DSHHEDGESGSEASD	BANP	171	Q8N9N5
HEQDGENSDEDSSGE	ERICH2	121	A1L162
HREGEAAGGDHETES	CDS1	21	Q92903
VADNNEDVDGDGVHE	AHI1	311	Q8N157
DEDHDEGFGSEHELS	CREBRF	366	Q8IUR6
EGFGSEHELSENEEE	CREBRF	371	Q8IUR6
EEEPGESLSHSEGDD	CHAF1A	606	Q13111
HEGPGHGEDETEGEE	CLSTN2	891	Q9H4D0
VEAQFDGSDSEDGHG	DIS3L2	166	Q8IYB7
GEQGESGEEGDSNED	AP3B1	701	O00203
GGQPHSEDDSSEEEH	RCOR2	26	Q8IZ40
TDGIEEDFDEDGGHE	RALYL	271	Q86SE5
GPETHDSEEDEGDED	RASEF	96	Q8IZ41
EEENDSLGADGTHGA	EDC4	481	Q6P2E9
GSDGEDDVNEQHSGS	IWS1	26	Q96ST2
DGEDENEEGTASEHG	FANCI	1301	Q9NVI1
QHSGSEAPNDDEDEG	LEO1	106	Q8WVC0
DISNGYDDSEDGGHT	MAP1B	1986	P46821
SDDEHDEHDENGATG	SSB	366	P05455
NEGEDEGEIHAEDGE	SLC24A1	806	O60721
EEETGAAEGAGEEAE	GJC2	156	Q5T442
DAGTEEGSDLFSDGH	KIF1B	946	O60333
DEQGDSEDDQAGSGE	GPATCH1	771	Q9BRR8
EESENEDEDGAGEAG	PNMA6F	556	A0A0J9YX94
VADNGDDHSEGGLVE	IGFBP2	146	P18065
DDFAESDEDEAHGPG	EHBP1L1	186	Q8N3D4
DSGDDSDSEHGDGTD	PHRF1	41	Q9P1Y6
SDSEHGDGTDGEDEG	PHRF1	46	Q9P1Y6
EGEESDVESHGNGLE	KDM4C	526	Q9H3R0
ENALHASEEEEGEGG	PRKD2	356	Q9BZL6
GESDEEEFQGFHSDE	KMT2B	116	Q9UMN6
ELDSDGDEDQGEGEA	LRGUK	71	Q96M69
SGHGDSEQGDSDHDA	PCDH10	911	Q9P2E7
ESSHGDGSELDDEGM	DMP1	201	Q13316
DEGSGSDEDENDEGN	PHF14	241	O94880
EESQGENTDGEETHS	PEG3	1061	Q9GZU2
ENTDGEETHSEETHG	PEG3	1066	Q9GZU2
DETEEGNGVETEDGA	KCNJ14	406	Q9UNX9
DVDGEDQSIGGDHSR	PCDHA10	781	Q9Y5I2
DEEEDEEHSGNDSDG	CDC45	136	O75419
EEHSGNDSDGSEPSE	CDC45	141	O75419
EHDGETEGSGLDESN	IGSF10	671	Q6WRI0
HDGEEAPQQFSEDGD	IGSF1	1196	Q8N6C5
GEECSDSEGSHNEEA	GIGYF2	331	Q6Y7W6
GHQSFQFDEDDGDGE	CCDC34	71	Q96HJ3
AEASDGESHGDGDRE	FNDC1	781	Q4ZHG4
SVNEHEDGDGDDDEG	KIF4A	1051	O95239
SVNEHEDGDGDGDSD	KIF4B	1051	Q2VIQ3
HEAGEGETEASLQEG	HAS3	156	O00219
AGHDGDSDGDSDDEE	EEF2K	21	O00418
DHSEEESEEGSGDLG	EML4	936	Q9HC35
DGEDEAEDTGVDTGA	FGFR3	136	P22607
PEDAVHEDSGDEDGE	HDAC2	386	Q92769
SRHSGGDDEGLQEEE	FAM110C	261	Q1W6H9
EAHADGGGDETAERT	SLC12A7	11	Q9Y666
VQDAGLAHEGEGEEE	SPACA1	36	Q9HBV2
LAHEGEGEEETENND	SPACA1	41	Q9HBV2
AEGAGDEEEAVHEAG	RYR1	4416	P21817
EGTQFSDGGEEDEED	NKX2-3	51	Q8TAU0
THGSDGDGDGEIVDE	C4orf19	276	Q8IY42
SEGEEDDEGEEHGLG	NEURL4	1106	Q96JN8
DDEGEEHGLGGQNEV	NEURL4	1111	Q96JN8
NDGEEEGESDGTHPV	PIP4K2A	296	P48426
STEVGRDHNEEEGEE	LRRFIP1	491	Q32MZ4
SEEEDDSHGEEGEPS	MINK1	326	Q8N4C8
ESDGGHSQKESEAEE	RPGR	626	Q92834
QFSEEEGDEEEEGGA	RSPH6A	501	Q9H0K4
SRGEQEGDEEEEGHI	POLR1A	1386	O95602
DDGDNDHEALGVGDN	URI1	316	O94763
DDEGSSEATEGHDED	SV2C	71	Q496J9
AETGHDGETENEGIT	RIF1	2031	Q5UIP0
GTLEDEDDDGQCGEH	MTF1	56	Q14872
DGRDSDEEGAEGHRD	PRRC2A	346	P48634
FHAVDEEGESGGESE	SLC9A4	751	Q6AI14
QEGDHEPSGSETEED	SMIM13	51	P0DJ93
GHRGHDGEDDEGEEE	HRC	181	P23327
HRGHGSEEDEDVSDG	HRC	216	P23327
DPGSHEEDDESSEQG	HRC	491	P23327
EEDDESSEQGEKGTH	HRC	496	P23327
HDDTAGGEEGENSPD	SP1	576	P08047
EGGASSDATEGHDED	SV2A	76	Q7L0J3
HAEAQGDEGDGEEGL	AHNAK2	546	Q8IVF2
DEDSGDEDSQRGAHL	PGBD2	56	Q6P3X8
NGHDGDTHQEDDGEK	TLE5	181	Q08117
EGSDSGDSEDDVGHK	SUPT6H	71	Q7KZ85
EEEEEEEEGSGHSTG	WEE1	36	P30291
TNGEDTEDEEFHGLD	VPS25	131	Q9BRG1
NSDESDAEGEHGDGA	UNC93B1	546	Q9H1C4
EGEAAQQEPEHGEDT	WDFY3	2461	Q8IZQ1
EEEHGTEESTGDADG	RREB1	1336	Q92766
EDDTGMGDEGEDSNE	TPR	1976	P12270
GEHSAGTEEGAEKEE	RYR3	1756	Q15413
EADTDDHQGTLGFEE	PLCH2	216	O75038
YSDEEEEGHNDTSDG	EZH1	186	Q92800
EEGHNDTSDGKQDDS	EZH1	191	Q92800
LIHGEDSDSEGEEEG	UBE2O	81	Q9C0C9
QDSEGREGSEAVEEH	HIVEP3	1831	Q5T1R4
HSDSDGEQEAEEGGV	WBP4	226	O75554
IHSSDEGEDQAGDED	WAS	481	P42768
FDHEEESEGDTDKDG	SENP6	36	Q9GZR1
GDDTESLHSQGEEEF	TP53BP1	1211	Q12888
GLGFSEVEDHDGEGD	SMAP	101	O00193
EVEDHDGEGDVAGDD	SMAP	106	O00193
EEDEEEAQGSGESDG	PPP6R1	626	Q9UPN7
EEDEASHSGGSGDEA	XRCC1	411	P18887
EGQDNGAEDSGDTED	XRCC1	476	P18887
EHDKSGEEEQGAEEG	PIEZO1	1816	Q92508
HGSEEREEGSHEQDE	TYW1	266	Q9NV66
GESDGDEFVHRDNGE	WBP11	281	Q9Y2W2
GHIDSYGADDSEEEG	PJA1	116	Q8NG27
HSDVEDSGESEEEGA	HIVEP1	486	P15822
DEQEEHGEENAEAEG	UBR5	1586	O95071
AEAEGQHDEHDEDGS	UBR5	1596	O95071
GSYHNEEDEEEDGGE	NACC1	276	Q96RE7
DEEDDEEHEGGGSRS	NAA30	41	Q147X3